Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Operations

v3.8.0.1
Consolidated Statement of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Net revenue $ 113,581 $ 96,324 $ 306,597 $ 300,696
Cost of net revenue 61,739 40,820 150,727 121,109
Gross profit 51,842 55,504 155,870 179,587
Operating expenses:        
Research and development 29,270 25,921 82,163 73,710
Selling, general and administrative 29,037 17,619 78,988 47,734
IPR&D impairment losses 2,000 1,300 2,000 1,300
Restructuring charges 2,178 0 8,724 2,106
Total operating expenses 62,485 44,840 171,875 124,850
Income (loss) from operations (10,643) 10,664 (16,005) 54,737
Interest income 1 89 260 426
Interest Expense (4,133) 0 (6,334) 0
Other income (expense), net (668) 10 (1,430) (64)
Total interest and other income (expense), net (4,800) 99 (7,504) 362
Income (loss) before income taxes (15,443) 10,763 (23,509) 55,099
Income tax provision (benefit) (6,276) 1,084 (33,770) 2,155
Net income (loss) $ (9,167) $ 9,679 $ 10,261 $ 52,944
Net income (loss) per share:        
Basic $ (0.14) $ 0.15 $ 0.16 $ 0.83
Diluted $ (0.14) $ 0.14 $ 0.15 $ 0.79
Shares used to compute net income (loss) per share:        
Basic 66,712 64,241 65,950 63,454
Diluted 66,712 67,832 69,491 67,354